but they say this is old tech, with exprired patents, with some confusing 'Pfizer offered to buy it' and no extra details. To me it seems they mostly want VC money from those who would bet on something unproven if the potential market is huge.
For a lot of non-software new tech you at least have a visible research group and at least some attempts at presenting peer reviewed papers.
